$4.93 Billion is the total value of Artal Group S.A.'s 146 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MANU | Exit | MANCHESTER UTD PLC NEWord cl a | $0 | – | -12,488 | -100.0% | -0.00% | – |
| PTGX | Exit | PROTAGONIST THERAPEUTICS INC | $0 | – | -75,000 | -100.0% | -0.03% | – |
| XLE | Exit | SELECT SECTOR SPDR TRcall | $0 | – | -50,000 | -100.0% | -0.04% | – |
| SHLS | Exit | SHOALS TECHNOLOGIES GROUP INcl a | $0 | – | -100,000 | -100.0% | -0.06% | – |
| GDS | Exit | GDS HLDGS LTDsponsored ads | $0 | – | -100,000 | -100.0% | -0.14% | – |
| TCOM | Exit | TRIP COM GROUP LTDads | $0 | – | -250,000 | -100.0% | -0.18% | – |
| TME | Exit | TENCENT MUSIC ENTMT GROUPsponsored ads | $0 | – | -550,000 | -100.0% | -0.20% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INCcall | $0 | – | -150,000 | -100.0% | -0.20% | – |
| IOVA | Exit | IOVANCE BIOTHERAPEUTICS INC | $0 | – | -400,000 | -100.0% | -0.22% | – |
| Z | Exit | ZILLOW GROUP INCcl c cap stk | $0 | – | -100,000 | -100.0% | -0.23% | – |
| KWEB | Exit | KRANESHARES TRcall | $0 | – | -200,000 | -100.0% | -0.27% | – |
| CPNG | Exit | COUPANG INCcl a | $0 | – | -400,000 | -100.0% | -0.35% | – |
| SLB | Exit | SCHLUMBERGER LTDcall | $0 | – | -1,000,000 | -100.0% | -0.48% | – |
| BEKE | Exit | KE HLDGS INCsponsored ads | $0 | – | -600,000 | -100.0% | -0.60% | – |
| AVGO | Exit | BROADCOM INC | $0 | – | -75,000 | -100.0% | -0.61% | – |
| CCXI | Exit | CHEMOCENTRYX INC | $0 | – | -750,000 | -100.0% | -0.68% | – |
| AA | Exit | ALCOA CORPcall | $0 | – | -1,500,000 | -100.0% | -0.86% | – |
| INTC | Exit | INTEL CORP | $0 | – | -800,000 | -100.0% | -0.90% | – |
| XBI | Exit | SPDR SER TRcall | $0 | – | -500,000 | -100.0% | -1.20% | – |
| BAC | Exit | BK OF AMERICA CORPcall | $0 | – | -2,000,000 | -100.0% | -1.37% | – |
| BNTX | Exit | BIONTECH SEsponsored ads | $0 | – | -900,000 | -100.0% | -1.74% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AGENUS INC | 42 | Q3 2023 | 1.9% |
| IRONWOOD PHARMACEUTICALS INC | 42 | Q3 2023 | 0.3% |
| ALNYLAM PHARMACEUTICALS INC | 37 | Q3 2023 | 5.1% |
| LEXICON PHARMACEUTICALS INC | 34 | Q3 2023 | 20.6% |
| AMICUS THERAPEUTICS INC | 30 | Q3 2023 | 2.7% |
| BEIGENE LTD | 28 | Q3 2023 | 7.4% |
| BK OF AMERICA CORP | 28 | Q1 2021 | 4.3% |
| SAGE THERAPEUTICS INC | 28 | Q2 2023 | 1.9% |
| AGIOS PHARMACEUTICALS INC | 28 | Q2 2020 | 1.1% |
| NEKTAR THERAPEUTICS | 27 | Q2 2020 | 1.3% |
View Artal Group S.A.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| WEIGHT WATCHERS INTERNATIONAL INC | February 13, 2015 | 29,443,300 | 51.9% |
View Artal Group S.A.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-03-25 |
| 4 | 2024-03-13 |
| 4 | 2024-02-29 |
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-13 |
| 4 | 2023-10-16 |
| 13F-HR | 2023-08-11 |
| 4 | 2023-06-22 |
| 3 | 2023-06-15 |
| 4 | 2023-06-05 |
View Artal Group S.A.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.